Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 3.500
-0.200 (-5.41%)
Nov 3, 2026, 10:03 AM HKT
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.36 billion as of November 2, 2026. It is the 21,412th most valuable company in the world and the 991st biggest in Hong Kong. Its market cap has increased by 11.64% in one year.
Market Cap
1.36B
Enterprise Value
822.10M
Revenue
63.74M
Global Rank
Country Rank
#991 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.36B, a decrease of -82.02%. That is a compound annual growth rate of -57.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.36B | -23.52% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.82B |
| Mabpharm | 1.75B |
| Clover Biopharmaceuticals | 1.62B |
| Guangzhou Innogen Pharmaceutical Group | 1.41B |
| SinoMab BioScience | 1.39B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.22B |
| PegBio | 1.20B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.11B |